Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

KCTD5 Peptide

For modified antibodies, we provide modified peptides(0.5mg) and non-modified peptides (0.5 mg).

Product Specifications

Reactivity

Antibody available as DF13105

Source

Synthetic

Applications

Blocking/Control

Concentration

10 mg/mL

Function

Blocking peptides are peptides that bind specifically to the target antibody and block antibody binding. These peptide usually contains the epitope recognized by the antibody. Antibodies bound to the blocking peptide no longer bind to the epitope on the target protein. This mechanism is useful when non-specific binding is an issue, for example, in Western blotting (immunoblot) and immunohistochemistry (IHC). By comparing the staining from the blocked antibody versus the antibody alone, one can see which staining is specific; Specific binding will be absent from the western blot or immunostaining performed with the neutralized antibody.

Precautions

This product is for research use only. Not for use in diagnostic or therapeutic procedures.

Related Products

DF13105

More Discoveries

Explore Other Products

Browse additional items from our catalog

Recilisib
BA8672-5.1 1 mL (10 mM in DMSO)

Recilisib

Sign In for Pricing
View Details
Lentiviral mouse Zfp810 shRNA (UAS) - Lentiviral mouseZfp810 shRNA (UAS, GFP) (25)
GTR15255752 1 Vial

Lentiviral mouse Zfp810 shRNA (UAS) - Lentiviral mouseZfp810 shRNA (UAS, GFP) (25)

Sign In for Pricing
View Details
ACTC1 CRISPRa sgRNA lentivector (set of three targets)(Human)
11244121 3x 1.0µg DNA

ACTC1 CRISPRa sgRNA lentivector (set of three targets)(Human)

Sign In for Pricing
View Details
Rontalizumab (Biosimilar Reference Antibody) (IFNA1)
RA0307-01 100 µg

Rontalizumab (Biosimilar Reference Antibody) (IFNA1)

Sign In for Pricing
View Details
Rontalizumab (Biosimilar Reference Antibody) (IFNA1)
RA0307-02 1 mg

Rontalizumab (Biosimilar Reference Antibody) (IFNA1)

Sign In for Pricing
View Details
Rontalizumab (Biosimilar Reference Antibody) (IFNA1)
RA0307-03 5 mg

Rontalizumab (Biosimilar Reference Antibody) (IFNA1)

Sign In for Pricing
View Details